Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6646 AL 6660

Recent advances in Lewy body dementia: A comprehensive review

Prasad S, Katta MR, Abhishek S, Sridhar R, Valisekka SS, Hameed M, Kaur J, Walia N.

Dis Mon. 2023 May;69(5):101441. doi: 10.1016/j.disamonth.2022.101441. Epub 2022 Jun 9.

Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases

Perez FP, Bandeira JP, Perez Chumbiauca CN, Lahiri DK, Morisaki J, Rizkalla M.

J Biomed Sci. 2022 Jun 13;29(1):39. doi: 10.1186/s12929-022-00825-y.

Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation

Kumar D, Md Ashraf G, Bilgrami AL, Imtaiyaz Hassan M.

Drug Discov Today. 2022 Oct;27(10):103305. doi: 10.1016/j.drudis.2022.06.005. Epub 2022 Jun 18.

Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases

Fan Y, Chen Z, Zhang M.

J Transl Med. 2022 Jun 27;20(1):291. doi: 10.1186/s12967-022-03493-6.

The role of microRNA-485 in neurodegenerative diseases

Ryu IS, Kim DH, Cho HJ, Ryu JH.

Rev Neurosci. 2022 Jul 7;34(1):49-62. doi: 10.1515/revneuro-2022-0039. Print 2023 Jan 27.

Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease

Khezri MR, Ghasemnejad-Berenji M.

Neurochem Res. 2022 Oct;47(10):2954-2962. doi: 10.1007/s11064-022-03667-0. Epub 2022 Jul 8.

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

Monti G, Gomes Moreira D, Richner M, Mutsaers HAM, Ferreira N, Jan A.

Cells. 2022 Jun 25;11(13):2023. doi: 10.3390/cells11132023.

Inosine in Neurodegenerative Diseases: From the Bench to the Bedside

Basile MS, Bramanti P, Mazzon E.

Molecules. 2022 Jul 21;27(14):4644. doi: 10.3390/molecules27144644.

Targeting endoplasmic reticulum stress using natural products in neurological disorders

Jangra A, Verma M, Kumar D, Chandrika, Rachamalla M, Dey A, Dua K, Jha SK, Ojha S, Alexiou A, Kumar D, Jha NK.

Neurosci Biobehav Rev. 2022 Oct;141:104818. doi: 10.1016/j.neubiorev.2022.104818. Epub 2022 Aug 5.

A review of stem cell therapy: An emerging treatment for dementia in Alzheimer's and Parkinson's disease

Pradhan AU, Uwishema O, Onyeaka H, Adanur I, Dost B.

Brain Behav. 2022 Sep;12(9):e2740. doi: 10.1002/brb3.2740. Epub 2022 Aug 15.

Recent Advancements in CNS Acting Drugs: A Step Towards End of Illness

Javed MN, Pottoo FH, Naim MJ, Chawla PA.

CNS Neurol Disord Drug Targets. 2022;21(10):882-883. doi: 10.2174/187152732110220722112205.

Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease

Katta M, Mathew BA, Chaturvedi P, Ludhiadch A, Munshi A.

Neurol Sci. 2023 Jan;44(1):19-36. doi: 10.1007/s10072-022-06356-6. Epub 2022 Sep 6.

Cell models for Alzheimer's and Parkinson's disease: At the interface of biology and drug discovery

Cetin S, Knez D, Gobec S, Kos J, Pišlar A.

Biomed Pharmacother. 2022 May;149:112924. doi: 10.1016/j.biopha.2022.112924. Epub 2022 Apr 8.

Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature

Alhowail A, Alsikhan R, Alsaud M, Aldubayan M, Rabbani SI.

Drug Des Devel Ther. 2022 Aug 31;16:2919-2931. doi: 10.2147/DDDT.S367229. eCollection 2022.

Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease

Goyal A, Verma A, Dubey N, Raghav J, Agrawal A.

J Food Biochem. 2022 Dec;46(12):e14415. doi: 10.1111/jfbc.14415. Epub 2022 Sep 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias